Gene: PRSS35
Official Full Name: serine protease 35provided by HGNC
Gene Summary: Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14841 | PRSS35 Knockout cell line (A549) | Human | PRSS35 | 1:3~1:4 | Negative | Online Inquiry |
PRSS35 Gene Knockout Cell Lines are a specialized tool designed for the study of the PRSS35 gene, which encodes a serine protease involved in various physiological processes. These cell lines have been genetically modified to disrupt the PRSS35 gene, allowing researchers to investigate the gene's function, mechanisms, and its role in disease states. By providing a controlled environment where PRSS35 activity is eliminated, these cell lines facilitate critical insights into protease activities, signal transduction, and potential therapeutic targets.
The key function of PRSS35 Gene Knockout Cell Lines lies in their ability to mimic a loss-of-function model, offering a unique perspective on PRSS35-associated pathways. The knockout mechanism eliminates the expression of the PRSS35 protein, enabling scientists to delineate the direct and indirect effects of this serine protease on cellular functions and interactions. Researchers can utilize these cell lines in assays exploring cell proliferation, apoptosis, and response to various stressors, providing invaluable data for both basic and applied biomedical research.
In clinical and research settings, PRSS35 Gene Knockout Cell Lines are crucial for understanding diseases wherein serine proteases play significant roles, such as inflammation and cancer progression. Their utility in drug screening and disease modeling contributes substantially to therapeutic advancements, making them indispensable in translational medicine.
Compared to alternative models, PRSS35 Gene Knockout Cell Lines boast a higher specificity and reliability in studying the PRSS35 gene's effects. Unlike chemically induced or transient knockdowns, these stable knockout lines offer consistency and reproducibility ideal for long-term studies and complex experimental designs.
For researchers and clinicians aiming to advance their understanding of protease biology, these cell lines represent a paramount resource. Our commitment to high-quality genetic modification techniques ensures that our PRSS35 Gene Knockout Cell Lines meet stringent research standards, supported by our team's expertise in cellular biology and genetics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.